Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04452149 · ClinicalTrials.gov registry record · NA
Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 826
- Enrollment target
NCT04452149 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 826 participants.
The verdict
NCT04452149, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 826 participants
- Enrollment target
Study Summary
The ALLEVIATE-HF study is a prospective, randomized, controlled, blinded, multi-site, interventional, investigational device exemption (IDE) pivotal study. The purpose of the study is to demonstrate the safety and efficacy of a patient management pathway that utilizes an integrated device diagnostic-based risk stratification algorithm to guide patient care in subjects with NYHA class II and III heart failure, and to demonstrate the safety of the Reveal LINQ™ system and procedure in the study population.
Interventions
- DEVICE Reveal LINQ™ Insertable Cardiac Monitor with investigational ALLEVIATE-HF RAMware download
- OTHER Medication intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 826 participants |
| Start Date | 2020-09-03 |
| Est. Completion | 2025-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04452149
The ClinicalTrials.gov registry entry for NCT04452149 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 826 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Reveal LINQ™ Insertable Cardiac Monitor with investigational ALLEVIATE-HF RAMware download is the first listed.
NCT04452149 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04452149 about?
NCT04452149 is a clinical study titled "Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure". The ALLEVIATE-HF study is a prospective, randomized, controlled, blinded, multi-site, interventional, investigational device exemption (IDE) pivotal study. The purpose of the study is to demonstrate the safety and efficacy of a patient management pathway that utilizes an integrated device diagnostic...
What is the current status of trial NCT04452149?
This trial is currently completed. It is a NA study. The enrollment target is 826 participants. The study started on 2020-09-03. Estimated completion is 2025-06-02.
What interventions are being tested in trial NCT04452149?
The interventions under investigation include: Reveal LINQ™ Insertable Cardiac Monitor with investigational ALLEVIATE-HF RAMware download (DEVICE), Medication intervention (OTHER).
Who is sponsoring clinical trial NCT04452149?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.